documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
- comment_end_date
- A FULL UTC INSTANT, not a calendar date, despite the column name: '2026-08-29T03:59:59Z' is 11:59:59 PM EASTERN on 2026-08-28. Federal comment periods close at 11:59:59 PM Eastern, so the UTC calendar date is ONE DAY LATER than the official deadline on every end-of-day close — 444,689 of the 444,690 populated rows (measured 2026-09-06). Convert to America/New_York before presenting a deadline, and compare with julianday(comment_end_date) > julianday('now'): a plain > datetime('now') is a TEXT comparison between two different formats and keeps already-closed dockets matching for up to ~20 hours. The sibling column on open_comments.documents WAS corrected to an Eastern calendar date (queue #498); this one is unchanged and still an instant — the two databases do not agree on grain. (queue #644)
- comment_start_date
- A FULL UTC INSTANT, not a calendar date, despite the column name — same grain as comment_end_date on this table. Convert to America/New_York before presenting it. (queue #644)
316,840 rows where document_type = "Notice" sorted by posted_date descending
This data as json, CSV (advanced)
posted_year >30
- 2006 17,528
- 2024 16,166
- 2013 15,687
- 2014 15,686
- 2016 15,200
- 2015 14,834
- 2020 14,734
- 2012 14,704
- 2017 14,666
- 2022 14,502
- 2021 14,438
- 2018 14,416
- 2011 14,203
- 2019 14,203
- 2023 14,007
- 2007 13,791
- 2010 13,720
- 2009 12,427
- 2025 12,121
- 2008 11,709
- 2005 7,212
- 2026 3,696
- 2004 3,238
- 2003 3,177
- 2002 2,450
- 2001 1,626
- 2000 1,570
- 1999 1,266
- 1998 1,215
- 1996 1,065
- …
agency_id >30
- SEC 40,880
- FERC 36,639
- EPA 22,691
- FDA 20,143
- NIH 13,111
- ITA 13,105
- FMCSA 12,886
- DOT 11,536
- NRC 9,599
- FAA 8,662
- FEMA 7,753
- HUD 6,287
- VA 6,126
- FCC 6,017
- CMS 5,041
- USPS 4,633
- DOE 4,487
- DOD 3,782
- NSF 3,705
- STB 3,679
- ED 3,511
- USDA 3,350
- FS 3,119
- USCG 2,954
- OSHA 2,918
- MARAD 2,860
- DOL 2,452
- FRA 2,447
- FMC 2,399
- CDC 2,224
- …
document_type 1
- Notice · 316,840 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-0004-0002 | FDA | Notice of Availability when we issue Emergency Use Authorizations (EUAs) for New World Screwworm FDA-2026-N-0004 | Authorization of Emergency Use for Four Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability | Notice | Notice of Availability | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T17:36:31Z | 2026-21084 | 0 | 0 | 09000064b967171d | |
| FDA-2026-N-1832-0079 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1344 - Part 1 of 2 - L-theanine (chemically synthesized) | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:36:14Z | 0 | 0 | 09000064b966c808 | ||
| FDA-2026-N-1832-0074 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1339 - L-ergothioneine produced by Escherichia coli EG38, expressing enzymes from Mycolicibacterium smegmatis, Schizophyllum commune H4-8, and Claviceps purpurea | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:35:17Z | 0 | 0 | 09000064b966cc7d | ||
| FDA-2026-N-1832-0075 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1340 - L-ergothioneine produced by Escherichia coli K12 MG1655, expressing enzymes from Mycolicibacterium smegmatis, Methylobacterium pseudosasicola, Microcoleus sp. PCC 7713, and Neurospora crassa | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:35:21Z | 0 | 0 | 09000064b966cc7e | ||
| FDA-2026-N-1832-0087 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1350 - Part 2 of 2 - Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:38:34Z | 0 | 0 | 09000064b966cc86 | ||
| FDA-2026-N-1832-0072 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1337 - Heat-killed Lacticaseibacillus paracasei 327 | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:35:01Z | 0 | 0 | 09000064b966cc7b | ||
| FDA-2026-N-1832-0078 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1343 - L-ergothioneine produced by Escherichia coli CGMCC 24897, expressing enzymes from Trichoderma reesei ATCC 13631 | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:35:55Z | 0 | 0 | 09000064b966cc81 | ||
| FDA-2026-N-1832-0080 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1344 - Part 2 of 2 - L-theanine (chemically synthesized) | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:36:19Z | 0 | 0 | 09000064b966ecd9 | ||
| FDA-2026-N-1832-0076 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1341 - Alternansucrase enzyme preparation produced by Escherichia coli expressing a gene encoding an alternansucrase enzyme from Leuconostoc mesenteroides | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:35:39Z | 0 | 0 | 09000064b966cc7f | ||
| FDA-2026-N-1832-0077 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1342 - D-psicose | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:35:51Z | 0 | 0 | 09000064b966cc80 | ||
| FDA-2026-N-1832-0085 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1349 - Polysorbate 65 | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:38:20Z | 0 | 0 | 09000064b966cc84 | ||
| FDA-2026-N-1832-0092 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1355 - Rebaudioside M9 produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:39:12Z | 0 | 0 | 09000064b966cc8a | ||
| FDA-2026-N-1832-0081 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1345 - Bacillus subtilis NCIMB 30283 | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:36:49Z | 0 | 0 | 09000064b966ecda | ||
| FDA-2026-N-1832-0090 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1353 - L-ergothioneine produced by Escherichia coli strain ERG2201 expressing genes encoding enzymes from Methylobacterium aquaticum, Trichoderma reesei, and Mycolicibacterium smegmatis | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:39:04Z | 0 | 0 | 09000064b966ecde | ||
| FDA-2026-N-1832-0094 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1358 - Lacticaseibacillus paracasei subsp. paracasei GDMCC 60960 | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:40:24Z | 0 | 0 | 09000064b966ece0 | ||
| FDA-2026-N-1832-0091 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1354 - Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:39:08Z | 0 | 0 | 09000064b966cc89 | ||
| FDA-2026-N-1832-0082 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1346 - Saccharomyces pastorianus “BY-1198” expressing a gene encoding an α-acetolactate decarboxylase enzyme from Acetobacter aceti | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:37:29Z | 0 | 0 | 09000064b966ecdb | ||
| FDA-2026-N-1832-0093 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1357 - Yeast protein produced by a non-genetically engineered Saccharomyces cerevisiae strain | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:40:20Z | 0 | 0 | 09000064b966ecdf | ||
| FDA-2026-N-1832-0084 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1348 - β-casein protein preparation | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:37:52Z | 0 | 0 | 09000064b966cc83 | ||
| FDA-2026-N-1832-0086 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1350 - Part 1 of 2 - Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:38:29Z | 0 | 0 | 09000064b966cc85 | ||
| FDA-2026-N-1832-0089 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1352 - 6-phytase enzyme preparation produced by Trichoderma reesei expressing a gene encoding 6-phytase from Escherichia coli | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:38:55Z | 0 | 0 | 09000064b966ecdc | ||
| FDA-2026-N-11624-0001 | FDA | Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee FDA-2026-N-11624 | Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee (TPSAC) | Notice | Request for Nominations | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T16:58:08Z | 2026-21027 | 0 | 0 | 09000064b9671769 | |
| FDA-2026-N-1832-0073 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1338 - Brazzein preparation produced by a genetically engineered strain of Komagataella phaffii “BG12” expressing a gene encoding for brazzein from Pentadiplandra brazzeana | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:35:05Z | 0 | 0 | 09000064b966cc7c | ||
| FDA-2026-N-1832-0083 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1347 - Lactobacillus plantarum KCTC 13101BP | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:37:49Z | 0 | 0 | 09000064b966cc82 | ||
| FDA-2026-N-1832-0088 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1351 - Heat-killed biomass of Xanthobacter sp. DSM 34079 | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:38:48Z | 0 | 0 | 09000064b966cc87 | ||
| FDA-2026-N-1832-0095 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1359 - Bifidobacterium animalis subsp. lactis CCTCC M 2013336 | Notice | General Notice | 2026-10-15T04:00:00Z | 2026 | 10 | 2026-10-15T04:00:00Z | 2026-10-15T19:40:33Z | 0 | 0 | 09000064b966ece1 | ||
| APHIS-2026-0001-0007 | APHIS | Ball Horticultural Company: Availability of a Petition for a Determination of Nonregulated Status and Draft Plant Pest Risk Assessment for Red Flower Petal African marigold (Tagetes erecta) Event pBALL123-022-BE113. APHIS-2026-0001 | Determination of Nonregulated Status: Ball Horticultural Co.; Red Flower Petals African marigold (Tagetes erecta) Event pBALL123-022-BE113 3 | Notice | Determinations | 2026-10-14T04:00:00Z | 2026 | 10 | 2026-10-14T04:00:00Z | 2026-10-14T16:56:41Z | 2026-20961 | 0 | 0 | 09000064b966afff | |
| FDA-2026-N-0008-0017 | FDA | Advisory Committee FDA-2026-N-0008 | Advisory Committee; Cellular, Tissue, and Gene Therapies Advisory Committee; Renewal | Notice | Notice of Renewal | 2026-10-14T04:00:00Z | 2026 | 10 | 2026-10-14T04:00:00Z | 2026-10-14T18:23:42Z | 2026-20989 | 0 | 0 | 09000064b966b003 | |
| FDA-2026-N-7131-0008 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Infant Formula Requirements FDA-2026-N-7131 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Infant Formula Requirements | Notice | 30 Day Proposed Information Collection | 2026-10-14T04:00:00Z | 2026 | 10 | 2026-10-14T04:00:00Z | 2026-11-14T04:59:59Z | 2026-10-14T18:28:35Z | 2026-20980 | 1 | 0 | 09000064b966affd |
| FDA-2026-N-6739-0004 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Cosmetic Labeling Requirements and Facility Registration and Cosmetic Product Listing Program FDA-2026-N-6739 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Requirements for Cosmetic Products | Notice | 30 Day Proposed Information Collection | 2026-10-14T04:00:00Z | 2026 | 10 | 2026-10-14T04:00:00Z | 2026-11-14T04:59:59Z | 2026-10-14T18:20:53Z | 2026-20990 | 1 | 0 | 09000064b966b085 |
| FDA-2026-N-7338-0003 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Voluntary National Retail Food Regulatory Program Standards FDA-2026-N-7338 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Voluntary National Retail Food Regulatory Program Standards | Notice | 30 Day Proposed Information Collection | 2026-10-14T04:00:00Z | 2026 | 10 | 2026-10-14T04:00:00Z | 2026-11-14T04:59:59Z | 2026-10-14T19:15:47Z | 2026-20981 | 1 | 0 | 09000064b966aeb3 |
| USDA_FRDOC_0001-3378 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-10-14T04:00:00Z | 2026 | 10 | 2026-10-14T04:00:00Z | 2026-10-14T16:53:15Z | 2026-20985 | 0 | 0 | 09000064b965c83e | ||
| FDA-2024-D-2581-0010 | FDA | Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers; Draft Guidance for Industry; Availability FDA-2024-D-2581 | Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers; Guidance for Industry; Availability | Notice | Notice of Availability | 2026-10-13T04:00:00Z | 2026 | 10 | 2026-10-13T04:00:00Z | 2026-10-13T20:18:36Z | 2026-20817 | 0 | 0 | 09000064b965c59f | |
| EPA_FRDOC_0001-33209 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Environmental Impact Statements; Availability, etc. | Notice | 2026-10-09T04:00:00Z | 2026 | 10 | 2026-10-09T04:00:00Z | 2026-10-09T16:26:04Z | 2026-20738 | 0 | 0 | 09000064b9657796 | ||
| FDA-2026-N-10835-0001 | FDA | Par Health USA LLC, U.S. Agent for PH Health Limited et al.; Withdrawal of Approval of 37 Abbreviated New Drug Applications FDA-2026-N-10835 | Par Health USA LLC, U.S. Agent for PH Health Limited, et al.; Withdrawal of Approval of 37 Abbreviated New Drug Applications | Notice | Withdrawal | 2026-10-09T04:00:00Z | 2026 | 10 | 2026-10-09T04:00:00Z | 2026-10-09T18:48:57Z | 2026-20762 | 0 | 0 | 09000064b96576b4 | |
| FDA-2026-N-7426-0003 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Expanded Access to Investigational Drugs for Treatment Use FDA-2026-N-7426 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Expanded Access to Investigational Drugs for Treatment Use | Notice | 30 Day Proposed Information Collection | 2026-10-09T04:00:00Z | 2026 | 10 | 2026-10-09T04:00:00Z | 2026-11-10T04:59:59Z | 2026-10-09T18:12:21Z | 2026-20765 | 1 | 0 | 09000064b96577e0 |
| FDA-2014-N-0053-1398 | FDA | Designation of High-Risk Foods for Tracing; Request for Comments and for Scientific Data and Information FDA-2014-N-0053 | Challenges and Solutions in Lot-Level Food Traceability; Public Meeting | Notice | Public Meetings | 2026-10-09T04:00:00Z | 2026 | 10 | 2026-10-09T04:00:00Z | 2026-12-07T04:59:59Z | 2026-10-09T18:53:04Z | 2026-20720 | 1 | 0 | 09000064b9653e73 |
| FDA-2026-N-10786-0001 | FDA | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ZANVASTRO (zilganersen) FDA-2026-N-10786 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ZANVASTRO (Zilganersen) | Notice | Announcement | 2026-10-09T04:00:00Z | 2026 | 10 | 2026-10-09T04:00:00Z | 2026-10-09T18:42:00Z | 2026-20769 | 0 | 0 | 09000064b9657707 | |
| FDA-2026-N-5816-0002 | FDA | Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications FDA-2026-N-5816 | Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications; Correction | Notice | Correction | 2026-10-09T04:00:00Z | 2026 | 10 | 2026-10-09T04:00:00Z | 2026-10-09T18:36:17Z | 2026-20730 | 0 | 0 | 09000064b965774f | |
| FDA-2020-E-1882-0005 | FDA | Patent Term Extension Application for MONOFERRIC (ferric derisomaltose), Patent No. 8,815,301 FDA-2020-E-1882 | Determination of Regulatory Review Period for Purposes of Patent Extension; MONOFERRIC | Notice | Determinations | 2026-10-09T04:00:00Z | 2026 | 10 | 2026-10-09T04:00:00Z | 2026-12-09T04:59:59Z | 2026-10-09T18:22:03Z | 2026-20766 | 1 | 0 | 09000064b9657798 |
| FDA-2026-N-10396-0001 | FDA | Amneal Pharmaceuticals of New York, LLC; Withdrawal of Approval of Abbreviated New Drug Application for Celecoxib Capsules, 50 Milligrams, 100 Milligrams, 200 Milligrams, and 400 Milligrams FDA-2026-N-10396 | Amneal Pharmaceuticals of New York, LLC; Withdrawal of Approval of Abbreviated New Drug Application for Celecoxib Capsules, 50 Milligrams, 100 Milligrams, 200 Milligrams, and 400 Milligrams | Notice | Withdrawal | 2026-10-09T04:00:00Z | 2026 | 10 | 2026-10-09T04:00:00Z | 2026-10-09T18:15:50Z | 2026-20758 | 0 | 0 | 09000064b965779c | |
| FDA-2026-P-4567-0004 | FDA | Requests that the FDA determine whether the Reference Listed Drug (RLD) LASIX ORAL SOLUTION, 10 mg/mL; New Drug Application (NDA) 017688 of SANOFI AVENTIS US LLC has been voluntarily withdrawn from sale for safety or efficacy reasons. FDA-2026-P-4567 | Determination That LASIX (Furosemide) Oral Solution, 10 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2026-10-09T04:00:00Z | 2026 | 10 | 2026-10-09T04:00:00Z | 2026-10-09T17:53:11Z | 2026-20764 | 0 | 0 | 09000064b96577e3 | |
| FDA-2026-N-6667-0002 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Biologics License Applications (BLAs) FDA-2026-N-6667 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biologics License Applications, Procedures and Requirements | Notice | 30 Day Proposed Information Collection | 2026-10-09T04:00:00Z | 2026 | 10 | 2026-10-09T04:00:00Z | 2026-11-10T04:59:59Z | 2026-10-10T09:00:59Z | 2026-20768 | 1 | 0 | 09000064b9657794 |
| FDA-2020-E-1892-0005 | FDA | Patent Term Extension Application for MONOFERRIC (ferric derisomaltose), Patent No. 10,414,831 FDA-2020-E-1892 | Determination of Regulatory Review Period for Purposes of Patent Extension; MONOFERRIC | Notice | Determinations | 2026-10-09T04:00:00Z | 2026 | 10 | 2026-10-09T04:00:00Z | 2026-12-09T04:59:59Z | 2026-10-09T18:23:55Z | 2026-20766 | 1 | 0 | 09000064b965705e |
| APHIS-2021-0081-0042 | APHIS | Chrysanthemum white rust APHIS-2021-0081 | Imports: Chrysanthemum spp. Cuttings, and In Vitro Plantlets, and Synonymous Taxa; Decision to Deregulate Chrysanthemum White Rust | Notice | Availability of Environmental Assessment | 2026-10-08T04:00:00Z | 2026 | 10 | 2026-10-08T04:00:00Z | 2026-10-08T16:32:26Z | 2026-20631 | 0 | 0 | 09000064b9651f15 | |
| EPA-HQ-OPP-2025-0027-0004 | EPA | Transfer of Data EPA-HQ-OPP-2025-0027 | Access to Confidential Business Information: Eastern Research Group | Notice | 2026-10-08T04:00:00Z | 2026 | 10 | 2026-10-08T04:00:00Z | 2026-10-08T20:22:47Z | 2026-20639 | 0 | 0 | 09000064b9651d41 | ||
| EPA_FRDOC_0001-33206 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Hearings, Meetings, Proceedings, etc.: Clean Air Scientific Advisory Committee on Oxides of Nitrogen | Notice | 2026-10-08T04:00:00Z | 2026 | 10 | 2026-10-08T04:00:00Z | 2026-10-08T16:26:15Z | 2026-20608 | 0 | 0 | 09000064b9651e93 | ||
| FDA-2026-N-7129-0005 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Adverse Event Program for Medical Devices: (Medical Product Safety Network (MedSun)) FDA-2026-N-7129 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Adverse Event Program for Medical Devices: (Medical Product Safety Network (MedSun)) | Notice | 30 Day Proposed Information Collection | 2026-10-08T04:00:00Z | 2026 | 10 | 2026-10-08T04:00:00Z | 2026-11-10T04:59:59Z | 2026-10-08T17:19:42Z | 2026-20661 | 1 | 0 | 09000064b9651f14 |
| FDA-2026-N-10605-0001 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Channels of Trade Policy for Commodities With Residues of Pesticide Chemicals, for Which Tolerances Have Been Revoked, Suspended, or Modified by the Environmental Protection Agency Pursuant to Dietary Risk Considerations FDA-2026-N-10605 | Agency Information Collection Activities; Proposed Collection; Comment Request; Channels of Trade Policy for Commodities With Residues of Pesticide Chemicals, for Which Tolerances Have Been Revoked, Suspended, or Modified by the Environmental Protection Agency Pursuant to Dietary Risk Considerations | Notice | 60 Day Proposed Information Collection | 2026-10-08T04:00:00Z | 2026 | 10 | 2026-10-08T04:00:00Z | 2026-12-08T04:59:59Z | 2026-10-08T17:22:43Z | 2026-20663 | 1 | 0 | 09000064b9651d3d |
| FDA-2022-P-0558-0005 | FDA | Requests that the FDA to determine if the Reference Listed Drug (RLD), OXANDRIN (oxandrolone tablets, USP) 2.5 mg and 10 mg, NDA 013718 owned by Gemini Laboratories LLC was voluntarily withdrawn from sale for reasons of safety or effectiveness to facilitate the approval of generic version. FDA-2022-P-0558 | Determination That Oxandrin (Oxandrolone) Tablets, 2.5 Milligrams and 10 Milligrams, Were Withdrawn From Sale for Reasons of Safety or Effectiveness; Correction | Notice | Correction | 2026-10-07T04:00:00Z | 2026 | 10 | 2026-10-07T04:00:00Z | 2026-10-07T18:02:12Z | 2026-20503 | 0 | 0 | 09000064b96482e9 | |
| FWS-HQ-OC-2026-4027-0001 | FWS | Hunting and Shooting Sports Conservation and Access Council; Request for Nominations FWS-HQ-OC-2026-4027 | Hunting and Shooting Sports Conservation and Access Council; Request for Nominations | Notice | 2026-10-07T04:00:00Z | 2026 | 10 | 2026-10-07T04:00:00Z | 2026-10-07T16:48:22Z | 2026-20555 | 0 | 0 | 09000064b9643567 | ||
| FWS-R7-ES-2026-4357-0001 | FWS | Marine Mammals; Proposed Incidental Harassment Authorization for the Southern Beaufort Sea Stock of Polar Bears During Exploration Activities in the Arctic National Wildlife Refuge 1002 Area Alaska; Draft Environmental Assessment FWS-R7-ES-2026-4357 | Hunting and Shooting Sports Conservation and Access Council; Request for Nominations | Notice | 2026-10-07T04:00:00Z | 2026 | 10 | 2026-10-07T16:03:00Z | 0 | 1 | 09000064b9643561 | ||||
| EPA-HQ-OPPT-2026-1849-0016 | EPA | Certain New Chemicals or Significant New Uses; Statements of Findings for 2026 EPA-HQ-OPPT-2026-1849 | Certain New Chemicals or Significant New Uses: Statements of Findings—June 2026 | Notice | 2026-10-06T04:00:00Z | 2026 | 10 | 2026-10-06T04:00:00Z | 2026-10-06T17:36:31Z | 2026-20436 | 0 | 0 | 09000064b962e6ee | ||
| EPA-HQ-OAR-2021-0669-0009 | EPA | Yearly hydrofluorocarbon production and consumption allowances under the American Innovation and Manufacturing Act EPA-HQ-OAR-2021-0669 | 2027 Allowance Allocations for Production and Consumption of Regulated Substances under the American Innovation and Manufacturing Act, and Final Actions Establishing Administrative Consequences: Phasedown of Hydrofluorocarbons | Notice | 2026-10-06T04:00:00Z | 2026 | 10 | 2026-10-06T17:14:30Z | 2026-20389 | 0 | 0 | 09000064b962e77d | |||
| FDA-2026-N-11259-0001 | FDA | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; FAYUVI (rebisufligene etisparvovec-hopf) FDA-2026-N-11259 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; FAYUVI (rebisufligene etisparvovechopf) | Notice | Announcement | 2026-10-06T04:00:00Z | 2026 | 10 | 2026-10-06T04:00:00Z | 2026-10-06T18:28:00Z | 2026-20434 | 0 | 0 | 09000064b962e73a | |
| FDA-2026-P-3632-0007 | FDA | Requests that the FDA to determine that PRALIDOXIME CHLORIDE (AUTOINJECTOR) 600 mg/2 mL intramuscular solution, (NDA 018986) from Meridian Medical Technologies Inc. was not discontinued or withdrawn due to safety or efficacy reasons. FDA-2026-P-3632 | Determination PRALIDOXIME CHLORIDE (Autoinjector) (Pralidoxime Chloride) Solution, 600 Milligrams/2 Milliliters (300 Milligrams/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2026-10-06T04:00:00Z | 2026 | 10 | 2026-10-06T04:00:00Z | 2026-10-06T18:37:10Z | 2026-20442 | 0 | 0 | 09000064b962e6a8 | |
| FDA-2026-N-4291-0002 | FDA | Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications FDA-2026-N-4291 | Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications; Correction | Notice | Correction | 2026-10-06T04:00:00Z | 2026 | 10 | 2026-10-06T04:00:00Z | 2026-10-06T18:38:22Z | 2026-20460 | 0 | 0 | 09000064b962e6a7 | |
| FDA-2026-N-10429-0001 | FDA | Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information FDA-2026-N-10429 | Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information | Notice | Requests for Information (RFI) | 2026-10-06T04:00:00Z | 2026 | 10 | 2026-10-06T04:00:00Z | 2026-11-21T04:59:59Z | 2026-10-15T09:00:40Z | 2026-20427 | 1 | 0 | 09000064b962e7b9 |
| USDA_FRDOC_0001-3377 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-10-06T04:00:00Z | 2026 | 10 | 2026-10-06T04:00:00Z | 2026-10-06T17:03:20Z | 2026-20457 | 0 | 0 | 09000064b962e86b | ||
| USDA_FRDOC_0001-3376 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-10-06T04:00:00Z | 2026 | 10 | 2026-10-06T04:00:00Z | 2026-10-06T17:03:19Z | 2026-20449 | 0 | 0 | 09000064b962e6ed | ||
| EPA_FRDOC_0001-33194 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Environmental Impact Statements; Availability, etc. | Notice | 2026-10-02T04:00:00Z | 2026 | 10 | 2026-10-02T04:00:00Z | 2026-10-02T16:26:05Z | 2026-20240 | 0 | 0 | 09000064b96047fa | ||
| FDA-2025-N-1927-0104 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2024 FDA-2025-N-1927 | GRAS Notice (GRN) 1241 – Amendments – beta-lactoglobulin produced by Aspergillus oryzae | Notice | General Notice | 2026-10-02T04:00:00Z | 2026 | 10 | 2026-10-02T04:00:00Z | 2026-10-02T23:48:52Z | 0 | 0 | 09000064b95fccd7 | ||
| FDA-2025-N-1928-0079 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2025 FDA-2025-N-1928 | GRAS Notice (GRN) 1251 – Amendment – Saccharomyces cerevisiae expressing a gene encoding a cysteine-thiol lyase from Staphylococcus hominis (S. cerevisiae "OYR-290") | Notice | General Notice | 2026-10-02T04:00:00Z | 2026 | 10 | 2026-10-02T04:00:00Z | 2026-10-02T23:49:37Z | 0 | 0 | 09000064b95fccda | ||
| FDA-2025-N-1927-0103 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2024 FDA-2025-N-1927 | GRAS Notice (GRN) 1237 – Amendment – beta-glucanase enzyme preparation produced by Talaromyces versatilis | Notice | General Notice | 2026-10-02T04:00:00Z | 2026 | 10 | 2026-10-02T04:00:00Z | 2026-10-02T23:48:16Z | 0 | 0 | 09000064b95fccd6 | ||
| FDA-2025-N-1928-0080 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2025 FDA-2025-N-1928 | GRAS Notice (GRN) 1252 – Amendments – Saccharomyces cerevisiae "BY-1568" | Notice | General Notice | 2026-10-02T04:00:00Z | 2026 | 10 | 2026-10-02T04:00:00Z | 2026-10-02T23:49:59Z | 0 | 0 | 09000064b95fccdb | ||
| USDA_FRDOC_0001-3375 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-10-02T04:00:00Z | 2026 | 10 | 2026-10-02T04:00:00Z | 2026-10-02T16:25:39Z | 2026-20267 | 0 | 0 | 09000064b96046d0 | ||
| USDA_FRDOC_0001-3373 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-10-02T04:00:00Z | 2026 | 10 | 2026-10-02T04:00:00Z | 2026-10-02T16:25:30Z | 2026-20278 | 0 | 0 | 09000064b9604628 | ||
| USDA_FRDOC_0001-3374 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-10-02T04:00:00Z | 2026 | 10 | 2026-10-02T04:00:00Z | 2026-10-02T16:25:35Z | 2026-20237 | 0 | 0 | 09000064b960467d | ||
| FDA-2026-N-6876-0005 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Voluntary Improvement Program FDA-2026-N-6876 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Voluntary Improvement Program | Notice | 30 Day Proposed Information Collection | 2026-10-01T04:00:00Z | 2026 | 10 | 2026-10-01T04:00:00Z | 2026-11-03T04:59:59Z | 2026-10-01T17:10:26Z | 2026-20085 | 1 | 0 | 09000064b95fa835 |
| FDA-2026-N-0008-0014 | FDA | Advisory Committee FDA-2026-N-0008 | Request for Nominations for Individuals and Consumer Organizations for Advisory Committees | Notice | Request for Nominations | 2026-10-01T04:00:00Z | 2026 | 10 | 2026-10-01T04:00:00Z | 2026-10-01T17:17:08Z | 2026-20065 | 0 | 0 | 09000064b95fa717 | |
| FDA-2026-N-0008-0016 | FDA | Advisory Committee FDA-2026-N-0008 | Request for Nominations for Voting Members of Food and Drug Administration Advisory Committees | Notice | Request for Nominations | 2026-10-01T04:00:00Z | 2026 | 10 | 2026-10-01T04:00:00Z | 2026-10-01T17:22:06Z | 2026-20063 | 0 | 0 | 09000064b95f234b | |
| FDA-2026-N-0008-0015 | FDA | Advisory Committee FDA-2026-N-0008 | Advisory Committee; Antimicrobial Drugs Advisory Committee; Renewal | Notice | Notice of Renewal | 2026-10-01T04:00:00Z | 2026 | 10 | 2026-10-01T04:00:00Z | 2026-10-01T17:19:17Z | 2026-20142 | 0 | 0 | 09000064b95fa69a | |
| FDA-2026-N-0008-0013 | FDA | Advisory Committee FDA-2026-N-0008 | Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory Committee; Renewal | Notice | Notice of Renewal | 2026-10-01T04:00:00Z | 2026 | 10 | 2026-10-01T04:00:00Z | 2026-10-01T17:14:19Z | 2026-20141 | 0 | 0 | 09000064b95fa7f1 | |
| EPA_FRDOC_0001-33186 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Public Water System Supervision Program: State of Illinois; Approval | Notice | 2026-09-30T04:00:00Z | 2026 | 9 | 2026-09-30T04:00:00Z | 2026-09-30T23:02:08Z | 2026-19976 | 0 | 0 | 09000064b95f22fc | ||
| EPA_FRDOC_0001-33187 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Hearings, Meetings, Proceedings, etc.: Science Advisory Board | Notice | 2026-09-30T04:00:00Z | 2026 | 9 | 2026-09-30T04:00:00Z | 2026-09-30T20:10:24Z | 2026-20057 | 0 | 0 | 09000064b95f2301 | ||
| EPA-HQ-OAR-2026-4358-0007 | EPA | Information Collection Request: Renewable Fuel Standard (RFS) Program: Reporting and Recordkeeping Requirements for Biogas Regulatory Reform EPA-HQ-OAR-2026-4358 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Renewable Fuel Standard Program: Standards for 2023-2025 and Other Changes | Notice | Information Collection Request (ICR) | 2026-09-30T04:00:00Z | 2026 | 9 | 2026-09-30T04:00:00Z | 2026-10-31T03:59:59Z | 2026-09-30T19:40:12Z | 2026-20053 | 1 | 0 | 09000064b95f217a |
| FDA-2026-P-4574-0003 | FDA | Requests that the FDA determine whether the original formulation submitted for the Reference Listed Drng (RLD), ISTURSIA (osilodrostat) tablets 10 mg (Product Number 003); New Drug Application (NDA) 212801, held by RECORDATI RARE DISEASES INC has been voluntarily withdrawn from the commercial market or withdrawn from sale for reasons of safety or eff FDA-2026-P-4574 | Determination That ISTURISA (Osilodrostat) Tablets, 10 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2026-09-30T04:00:00Z | 2026 | 9 | 2026-09-30T04:00:00Z | 2026-09-30T20:10:10Z | 2026-19968 | 0 | 0 | 09000064b95f22ff | |
| FWS-HQ-NWRS-2025-1397-0006 | FWS | Agency Information Collection Activities; Interjurisdictional Invasive Species Rapid Response Program FWS-HQ-NWRS-2025-1397 | Agency Information Collection Activities; Interjurisdictional Invasive Species Rapid Response Team Program | Notice | 2026-09-30T04:00:00Z | 2026 | 9 | 2026-09-30T04:00:00Z | 2026-12-01T04:59:59Z | 2026-10-14T09:00:59Z | 2026-19969 | 1 | 0 | 09000064b95f29b2 | |
| FDA-2026-N-10132-0001 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Protection of Human Subjects and Institutional Review Boards FDA-2026-N-10132 | Agency Information Collection Activities; Proposed Collection; Comment Request; Protection of Human Subjects and Institutional Review Boards | Notice | 60 Day Proposed Information Collection | 2026-09-29T04:00:00Z | 2026 | 9 | 2026-09-29T04:00:00Z | 2026-12-01T04:59:59Z | 2026-09-29T17:15:35Z | 2026-19849 | 1 | 0 | 09000064b95e7083 |
| FDA-2025-P-0394-0004 | FDA | Request that FDA determine whether the Reference Listed Drug (RLD), Sulfadiazine Tablets, 500 mg under New Drug Application (NDA) 004122 held by Eli Lilly and Co., was voluntarily withdrawn from commercial distribution or withdrawn from sale for safety or efficacy reasons. FDA-2025-P-0394 | Determination That SULFADIAZINE (Sulfadiazine) Tablet, 500 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2026-09-29T04:00:00Z | 2026 | 9 | 2026-09-29T04:00:00Z | 2026-09-29T17:20:40Z | 2026-19921 | 0 | 0 | 09000064b95e707d | |
| FDA-2026-N-2743-0003 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a Master File in Support of Petitions; and Electronic Submission Using Food and Drug Administration Form 3503 FDA-2026-N-2743 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a Master File in Support of Petitions; and Electronic Submission Using Food and Drug Administration Form 3503 | Notice | 30 Day Proposed Information Collection | 2026-09-29T04:00:00Z | 2026 | 9 | 2026-09-29T04:00:00Z | 2026-10-30T03:59:59Z | 2026-09-29T17:13:03Z | 2026-19850 | 1 | 0 | 09000064b95e920c |
| FDA-2026-N-10505-0001 | FDA | FHTA LLC; Withdrawal of Approval of New Drug Application for Mysoline (Primidone) Suspension, 250 Milligrams/5 Milliliters FDA-2026-N-10505 | FHTA LLC; Withdrawal of Approval of New Drug Application for MYSOLINE (Primidone) Suspension, 250 Milligrams/5 Milliliters | Notice | Withdrawal | 2026-09-29T04:00:00Z | 2026 | 9 | 2026-09-29T04:00:00Z | 2026-09-29T17:09:02Z | 2026-19912 | 0 | 0 | 09000064b95e92f9 | |
| USDA_FRDOC_0001-3372 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-09-29T04:00:00Z | 2026 | 9 | 2026-09-29T04:00:00Z | 2026-09-29T16:25:38Z | 2026-19862 | 0 | 0 | 09000064b95e911b | ||
| EPA-HQ-OPP-2017-0751-0044 | EPA | Registration Review Interim Decisions; Notice of Availability EPA-HQ-OPP-2017-0751 | Pesticide Registration Review: 4-CPA Final Decision | Notice | 2026-09-28T04:00:00Z | 2026 | 9 | 2026-09-28T04:00:00Z | 2026-09-28T17:39:02Z | 2026-19744 | 0 | 0 | 09000064b95d3073 | ||
| EPA-HQ-OPP-2014-0544-0017 | EPA | 4-chlorophenoxyacetic acid (4-CPA) – Combined Work Plan, Summary Document, and Proposed Interim Registration Review Decision. Case Number 2115. EPA-HQ-OPP-2014-0544 | Pesticide Registration Review: 4-CPA Final Decision | Notice | 2026-09-28T04:00:00Z | 2026 | 9 | 2026-09-28T04:00:00Z | 2026-09-28T17:34:56Z | 2026-19744 | 0 | 0 | 09000064b95d727e | ||
| EPA-R06-OAR-2026-1323-0002 | EPA | Blue Marlin Offshore Port LLC (BMOP) - Deepwater Port (DWP), Proposed PSD Permit R6 PSD-DWP-GA10 and Proposed Title V Permit R6T5-DWP-GA10 EPA-R06-OAR-2026-1323 | 02. Public Notice Documents | Notice | 2026-09-28T04:00:00Z | 2026 | 9 | 2026-09-29T04:00:00Z | 2026-10-30T03:59:59Z | 2026-09-29T15:54:43Z | 1 | 0 | 09000064b91a7613 | ||
| EPA-HQ-OPP-2009-0361-14478 | EPA | Glyphosate Registration Review EPA-HQ-OPP-2009-0361 | Glyphosate Open Literature Search to Inform Human Health Risk Assessment | Notice | 2026-09-28T04:00:00Z | 2026 | 9 | 2026-09-28T04:00:00Z | 2026-09-28T18:28:22Z | 2026-19775 | 0 | 0 | 09000064b95d7125 | ||
| EPA_FRDOC_0001-33176 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Environmental Impact Statements; Availability, etc. | Notice | 2026-09-25T04:00:00Z | 2026 | 9 | 2026-09-25T04:00:00Z | 2026-09-25T16:25:48Z | 2026-19676 | 0 | 0 | 09000064b95c5450 | ||
| FDA-2025-N-6692-0002 | FDA | NOOH Proposal to Debar Jeffrey Thies FDA-2025-N-6692 | Jeffrey Thies: Final Debarment Order | Notice | Statutory Debarment | 2026-09-25T04:00:00Z | 2026 | 9 | 2026-09-25T04:00:00Z | 2026-09-25T22:46:01Z | 2026-19655 | 1 | 0 | 09000064b95c54e1 | |
| FDA-2026-N-9505-0001 | FDA | Robotically-Assisted Surgical Devices – Premarket Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability FDA-2026-N-9505 | Robotically-Assisted Surgical Devices—Premarket Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2026-09-25T04:00:00Z | 2026 | 9 | 2026-09-25T04:00:00Z | 2026-11-25T04:59:59Z | 2026-09-25T19:21:13Z | 2026-19704 | 1 | 0 | 09000064b95c549b |
| FDA-2026-N-10606-0001 | FDA | Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—New Drug Application (NDA) 219694 for atropine sulfate ophthalmic solution, 0.01% FDA-2026-N-10606 | Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01% | Notice | Request for Comments | 2026-09-25T04:00:00Z | 2026 | 9 | 2026-09-25T04:00:00Z | 2026-10-30T03:59:59Z | 2026-10-15T09:00:38Z | 2026-19700 | 1 | 0 | 09000064b95c540b |
| FDA-2026-C-10597-0001 | FDA | Filing of Color Additive Petition from Doehler GmbH; Request to Amend the Color Additive Regulations to Provide for the Safe Use of Calcium Sulfate in Various Foods at Levels Consistent with Good Manufacturing Practice FDA-2026-C-10597 | Filing of Color Additive Petition From Doehler GmbH; Request To Amend the Color Additive Regulations To Provide for the Safe Use of Calcium Sulfate in Various Foods at Levels Consistent With Good Manufacturing Practice | Notice | Announcement | 2026-09-25T04:00:00Z | 2026 | 9 | 2026-09-25T04:00:00Z | 2026-10-02T21:57:29Z | 2026-19658 | 0 | 0 | 09000064b95c6531 | |
| FDA-2025-N-7395-0002 | FDA | Proposal to Debar Naveed Aslam FDA-2025-N-7395 | Naveed Aslam: Final Debarment Order | Notice | Statutory Debarment | 2026-09-25T04:00:00Z | 2026 | 9 | 2026-09-25T04:00:00Z | 2026-09-25T20:59:18Z | 2026-19654 | 1 | 0 | 09000064b95c6607 | |
| FDA-2015-N-3326-0056 | FDA | Biosimilar User Fee Act FDA-2015-N-3326 | Reauthorization of the Biosimilar User Fee Act; Public Meeting; Request for Comments | Notice | Request for Comments | 2026-09-25T04:00:00Z | 2026 | 9 | 2026-09-25T04:00:00Z | 2026-11-26T04:59:59Z | 2026-10-06T09:00:35Z | 2026-19660 | 1 | 0 | 09000064b95c53b7 |
| USDA_FRDOC_0001-3371 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-09-25T04:00:00Z | 2026 | 9 | 2026-09-25T04:00:00Z | 2026-09-25T16:26:06Z | 2026-19629 | 0 | 0 | 09000064b95c6537 | ||
| EPA-HQ-OAR-2021-0124-0004 | EPA | NESHAP for Aluminum, Copper, and Other Non-Ferrous Foundries (40 CFR part 63, subpart ZZZZZZ) (Renewal) EPA-HQ-OAR-2021-0124 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: National Emission Standards for Hazardous Air Pollutants for Aluminum, Copper, and Other Non-Ferrous Foundries | Notice | Information Collection Request (ICR) | 2026-09-24T04:00:00Z | 2026 | 9 | 2026-09-24T04:00:00Z | 2026-10-27T03:59:59Z | 2026-09-25T09:00:33Z | 2026-19505 | 1 | 0 | 09000064b95bf69e |
| EPA-HQ-OW-2026-4852-0009 | EPA | Agency Information Collection Activities: Proposed Collection; Comment Request; Information Collection Request (ICR) for State Source Water Protection Programs EPA-HQ-OW-2026-4852 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: EPA Program Information on Source Water Protection (Renewal) | Notice | Information Collection Request (ICR) | 2026-09-24T04:00:00Z | 2026 | 9 | 2026-09-24T04:00:00Z | 2026-10-27T03:59:59Z | 2026-09-24T16:40:03Z | 2026-19502 | 1 | 0 | 09000064b95bf727 |
| EPA-HQ-OAR-2021-0098-0005 | EPA | NESHAP for the Surface Coating of Large Household and Commercial Appliances (40 CFR part 63, subpart NNNN) (Renewal) EPA-HQ-OAR-2021-0098 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: NESHAP for the Surface Coating of Large Household and Commercial Appliances | Notice | Information Collection Request (ICR) | 2026-09-24T04:00:00Z | 2026 | 9 | 2026-09-24T04:00:00Z | 2026-10-27T03:59:59Z | 2026-09-24T16:45:04Z | 2026-19499 | 1 | 0 | 09000064b95bf652 |
| EPA-R06-OAR-2021-0029-0114 | EPA | TX249 Texas Agreed Orders Regarding Planned Maintenance, Startup And Shutdown Emissions For Certain Electric Generating Units, submitted to EPA August 20, 2020 (TX-453, SIP) EPA-R06-OAR-2021-0029 | TX249x114 Notice of Availability for Public Comment; Reconsideration of Air Plan Disapproval: Texas; Control of Air Pollution from Visible Emissions and Particulate Matter. 3 pages | Notice | 2026-09-24T04:00:00Z | 2026 | 9 | 2026-09-24T04:00:00Z | 2026-10-27T03:59:59Z | 2026-10-13T09:01:00Z | 2026-19496 | 1 | 0 | 09000064b95bf723 | |
| EPA-HQ-OAR-2021-0105-0005 | EPA | NESHAP for Semiconductor Manufacturing (40 CFR part 63, Subpart BBBBB) (Renewal) EPA-HQ-OAR-2021-0105 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: NESHAP for Semiconductor Manufacturing | Notice | Information Collection Request (ICR) | 2026-09-24T04:00:00Z | 2026 | 9 | 2026-09-24T04:00:00Z | 2026-10-27T03:59:59Z | 2026-09-24T16:35:01Z | 2026-19504 | 1 | 0 | 09000064b95bf763 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;